ARTICLE | Clinical News
Topical benzoporphyrin derivative: Began a Phase I/II trial
November 14, 1994 8:00 AM UTC
Quadra Logic Technologies Inc. (QLTIF), Vancouver Product: Topical benzoporphyrin derivative (BPD) activated by light-emitting diodes (LEDs) Indication: Moderate to severe psoriasis, covering less tha...